Social Media Ideas for Cvs Caremark Corporation

CVS Health Corporation (CVS) Rose on Improving Execution and Payer Margin Outlook

CVS Caremark reaches settlement with FTC over insulin suit

Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring the PBM to stop preferring higher cost ver...

Omnicare LLC & CVS Reach $440M FCA Settlement

CVS enhances supports for patients taking GLP-1s

CVS Health is raising its guidance for the year as it blew past Wall Street analysts' expectations in the second quarter.

CVS Health Stock Is Beating the Market in 2026. Here's Why Wall Street Thinks It Can Soar Another 22%.

One of the pharmacy operator's segments is doing particularly well.

CVS Health Profits Hit $2.9 Billion As Firm Gets Handle On Aetna Costs

CVS Health's second quarter net income nearly tripled to $2.9 billion compared to the year ago quarter as the company gets a better handle on its Aetna health plan costs.

CVS Health nearly triples net income as Aetna's Medicare Advantage turnaround gains steam

CVS's Aetna turnaround shows how carriers are doubling down on MA even as they retreat from the ACA marketplace

CVS Opens First Pharmacy-Focused Locations

Prescription provider unveils five cities already home to such locales, with more to come.

DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division

FTC’s Caremark Settlement Raises the Stakes in PBM Antitrust Enforcement

The Federal Trade Commission has announced what it calls a major antitrust settlement with Caremark, resolving a closely watched case against one of the country’s largest pharmacy...

FTC’s Caremark Insulin Settlement Puts PBM Rebate Practices in the Antitrust Crosshairs

The FTC has announced a significant settlement with Caremark Rx LLC and Zinc Health Services LLC in its insulin-pricing antitrust matter, marking one of the clearest signals yet th...

Froedtert sues CVS over $18M in 340B drug discounts

Froedtert Hospital is suing CVS Health, alleging CVS improperly kept $18 million in reimbursements from the federal 340B drug discount program. The post Froedtert sues CVS over $18...

FTC’s Caremark Insulin Settlement Puts PBM Rebate Practices in the Antitrust Crosshairs

The FTC has announced a significant settlement with Caremark Rx LLC and Zinc Health Services LLC in its insulin-pricing antitrust matter, marking one of the clearest signals yet th...

Cardinal Health makes acquisition duo worth $360m for home care business advance

What Does CVS Stand For? Here’s the Story Behind the Company’s Name

*CVS now operates thousands of pharmacies and clinics, but its familiar three-letter name came from a much smaller retail business. The initials originally represented Consumer Val...

FTC’s Caremark Settlement Raises the Stakes in PBM Antitrust Enforcement

The Federal Trade Commission has announced what it calls a major antitrust settlement with Caremark, resolving a closely watched case against one of the country’s largest pharmacy...

Costco moves into Medicare business via SCAN Health Plan

2 Stocks That Could Capitalize on the GLP-1 Boom

They aren't the most prominent names in the GLP-1 space, but they are worth a second look.

A look at CVS’ march toward a simpler patient experience

CVS Health Chief Medical Officer Amy Compton-Phillips, M.D., joins senior writer Paige Minemyer to unpack initiatives such as CVS Health 100 and discuss what the ideal patient expe...

FTC, CVS unveil settlement in ongoing insulin pricing case

The Federal Trade Commission has officially inked a second settlement with one of the "Big Three" pharmacy benefit managers in an ongoing legal battle over insulin prices.

Costco launching Medicare Advantage plans with SCAN Group

US health executives weigh in on vertical integration, cost of care

Executives from the largest U.S. health care payers cited proactive management of high-risk patients, biosimilar use and site-of-care steerage as their top tactics to lower care co...

Cigna CEO: Express Scripts seeing 'significant early interest' from clients for new rebate-free PBM model

Cigna is raising its outlook for the year after beating the Street on both earnings and revenue in the second quarter of 2026.

Oncology company Thyme Care raises $125M, backed by Morgan Health, Humana and CVS Health Ventures

Thyme Care landed a series E financing round of more than $125 million backed by strategic payers and providers as it aims to expand beyond cancer care navigation.